Janux Therapeutics, Inc. (JANX) Tops Q1 EPS by 18c
Tweet
Share
E-mailGet Alerts JANX Hot Sheet
Join SI Premium – FREE
Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q1 EPS of ($0.39), $0.18 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $3.73 million versus the consensus estimate of $4.18 million.
For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
- PVH Corp. (PVH) Tops Q1 EPS by 19c, Offers Guidance
- SpaceX files for 555.56M share IPO at $135/sh
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
